Advent Pharma (DHA:ADVENT) Net Margin %: 0.00% (As of . 20)


DHA:ADVENT Advent Pharma Ltd DHA:ADVENT
29 GF Score
Price BDT15.70
View Full Analysis

What is Advent Pharma Net Margin %?

Advent Pharma DHA:ADVENT 29 Net Margin % is 0.00% as of . 20. GuruFocus rates DHA:ADVENT with a GF Score™ of 29/100. Among 956 Drug Manufacturers companies, Advent Pharma ranks worse than 104602.41% on this metric.

Net margin is calculated as Net Income divided by its Revenue. Advent Pharma's Net Income for the six months ended in . 20 was BDT0.00 Mil. Advent Pharma's Revenue for the six months ended in . 20 was BDT0.00 Mil. Therefore, Advent Pharma's net margin for the quarter that ended in . 20 was 0.00%.

The historical rank and industry rank for Advent Pharma's Net Margin % or its related term are showing as below:


DHA:ADVENT's Net Margin % is not ranked *
in the Drug Manufacturers industry.
Industry Median: 5.56
* Ranked among companies with meaningful Net Margin % only.

Advent Pharma  (DHA:ADVENT) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.

Advent Pharma Net Margin % Related Terms

Advent Pharma Net Margin % Historical Data

* Premium members only.

The historical data trend for Advent Pharma's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Advent Pharma Net Margin % Chart

Advent Pharma Annual Data
Trend
Net Margin %

Advent Pharma Semi-Annual Data
Net Margin %

DHA:ADVENT vs : Net Margin % Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Advent Pharma's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Advent Pharma Net Margin % vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Advent Pharma's Net Margin % distribution charts can be found below:

* The bar in red indicates where Advent Pharma's Net Margin % falls into.


DHA:ADVENT
29GF Score
Advent Pharma Ltd DHA:ADVENT
Net Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Advent Pharma Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Advent Pharma's Net Margin for the fiscal year that ended in . 20 is calculated as

Net Margin=Net Income (A: . 20 )/Revenue (A: . 20 )
=/
= %

Advent Pharma's Net Margin for the quarter that ended in . 20 is calculated as

Net Margin=Net Income (Q: . 20 )/Revenue (Q: . 20 )
=/
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Net Margin % →
What does a Net Margin % of 0.00% mean?
Advent Pharma (DHA:ADVENT) has a Net Margin % of 0.00% as of . 20. Net margin is the ratio of total net income to net sales. View historical data on Advent Pharma and its competitors. According to the industry distribution chart, Advent Pharma ranks #999999 out of 956 companies in the Drug Manufacturers industry.
Is Advent Pharma's Net Margin % too high?
Advent Pharma's current Net Margin % is 0.00%. Based on the distribution chart, Advent Pharma ranks #999999 out of 956 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Advent Pharma has a GF Score™ of 29/100, reflecting its overall financial health beyond just this single metric.
How does Advent Pharma's Net Margin % compare to ?
According to the Drug Manufacturers industry distribution chart, Advent Pharma ranks #999999 out of 956 companies for Net Margin %. This places Advent Pharma in the lower half of its industry. The industry median Net Margin % is 5.56. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Drug Manufacturers company?
The median Net Margin % among Drug Manufacturers companies is 5.56, based on 956 companies in the industry. Companies in the top quartile (top 25%) have a Net Margin % significantly above this median, while those in the bottom quartile fall well below. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Advent Pharma and its competitors. For the Drug Manufacturers industry, the median Net Margin % is 5.56 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Advent Pharma's current Net Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Advent Pharma stock overvalued right now?
Advent Pharma (DHA:ADVENT) has a current Net Margin % of 0.00%. The current Net Margin % is 0.00%. Advent Pharma's overall GF Score™ is 29/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For Advent Pharma (DHA:ADVENT), the current Net Margin % is 0.00% as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Advent Pharma Business Description

Comparable Companies
Address Kakrail V.I.P. Road, Level no. 10, 80, Rupayan Karim Tower, Kakrail, Ramna, Dhaka, BGD, 1000
Advent Pharma Ltd is a Bangladesh-based company engaged in producing animal healthcare drugs and nutritional supplements for livestock.
29GF Score

Get the complete analysis for DHA:ADVENT

Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

BDT15.70
Price